Zydus Lifesciences’ anaemia drug Desidustat gets China approval
China’s drug regulator, the NMPA, has approved a treatment for renal anaemia in adult CKD patients not on dialysis
China’s drug regulator, the NMPA, has approved a treatment for renal anaemia in adult CKD patients not on dialysis
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
